The medical technology industry is becoming increasingly global, and innovation processes emphasize cost-effective health care solutions and translatable clinical outcomes. Rice University is preparing engineers to work in this new and changing environment with a focus on emerging markets.
The Rice University Department of Bioengineering expanded its non-thesis master of bioengineering (MBE) degree program through the launch of a unique track in Global Medical Innovation (GMI). Directed by Eric Richardson, Ph.D., the GMI program is designed to educate and train engineers for careers in medical technology through education in innovation, emerging-market design projects, and internships. The track builds on Rice’s top-ranked bioengineering programs, its award-winning design facilities at the Oshman Engineering Design Kitchen, the successful history of innovation in the developing world with Rice 360°: Institute for Global Health Technologies, and strong collaborations with the Texas Medical Center.
The GMI program specifically targets students who have an undergraduate degree in engineering (mechanical, electrical, chemical, or bioengineering/medical) or a related field, and who are interested in pursuing a career in the private, public, or non-profit sectors of medical technology.
The 2017-18 GMI cohort’s summer experience began on May 31, 2017. They traveled to Costa Rica, where they will spend ten weeks collaborating with local universities and clinicians to develop design projects, then take part in a global industry internship working as interns at Boston Scientific. We invite you to read their blog here: gmi.rice.edu/student-blogs.
GMI will begin accepting accepting applications for the 2018-19 academic year on September 1, 2017. For more information about the Global Medical Innovation MBE program, visit http://bioengineering.rice.edu/MBE.aspx. We’re also on Facebook at www.facebook.com/ricegmi.
Questions about the GMI track can be sent to email@example.com.